A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

NCT05755906 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BFF MDI 160/9.6 μg BID (320/19.2μg/day)
DRUG: BD MDI 160 μg BID (320 μg/day)

Sponsor

AstraZeneca